| Serial Number | 97669399 |
| Word Mark | ALERTAE DIGITAL RISK MITIGATION |
| Filing Date | Wednesday, November 9, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, May 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 26, 2023 |
| Description of Mark | The mark consists of the word "ALERTAE" in black with the top of the letter "T" in purple and blue shades and bearing a heart rate design. Below "ALERTAE" are the stylized words "DIGITAL RISK MITIGATION" in black. To the left of all the wording is a stylized partial globe depicted by a series of purple and blue dots. The color white represents background only and is not a feature of the mark. |
| Indication of Colors claimed | The color(s) purple, blue, and black is/are claimed as a feature of the mark. |
| Goods and Services | Business intelligence services, namely, data analytics and business or customer information analysis, in the fields of pharma and healthcare; marketing analysis services to provide trends and to gain insight into consumer behavior; marketing analysis and marketing services, namely, monitoring and administration of branded social media advertising for others; business research and analysis in the field of health care, biotechnology, pharmaceuticals, medical devices, healthcare technology, and health-related risk mitigation products and services; custom business research and market research services, and execution, analysis, and reporting of the same research |
| NOT AVAILABLE | "DIGITAL RISK MITIGATION" |
| Goods and Services | Technical support services, namely, troubleshooting of computer software problems; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; platform as a service ("PAAS") featuring computer software platforms for continuous monitoring of compliance and risk mitigation in regulated industries such as pharmaceuticals |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 29, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 29, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HCL Technologies Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | New Delhi 110019 IN |
| Party Name | HCL Technologies Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | New Delhi 110019 IN |
| Event Date | Event Description |
| Saturday, November 12, 2022 | NEW APPLICATION ENTERED |
| Tuesday, November 29, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 30, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, April 25, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 24, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, April 25, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 25, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 25, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 25, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 26, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 23, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, August 23, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 23, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 23, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, September 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 26, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 23, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, December 29, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, December 29, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 21, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, May 21, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, May 21, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 22, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 29, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |